|
Volumn 39, Issue 3, 2001, Pages 949-953
|
Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: Results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B;
ANTIFUNGAL AGENT;
FLUCONAZOLE;
FLUCYTOSINE;
ITRACONAZOLE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
ARTICLE;
BLOOD CULTURE;
CANDIDA;
CANDIDIASIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FUNGUS IDENTIFICATION;
HUMAN;
LEUKEMIA;
MAJOR CLINICAL STUDY;
MINIMUM INHIBITORY CONCENTRATION;
MORTALITY;
MULTICENTER STUDY;
NONHUMAN;
PREVALENCE;
PRIORITY JOURNAL;
STRAIN DIFFERENCE;
AMPHOTERICIN B;
ANTIFUNGAL AGENTS;
BLOOD;
CANDIDA;
CANDIDIASIS;
CROSS INFECTION;
FLUCYTOSINE;
HUMANS;
MICROBIAL SENSITIVITY TESTS;
POPULATION SURVEILLANCE;
PREVALENCE;
QUEBEC;
CANDIDA;
CANDIDA ALBICANS;
CANDIDA GLABRATA;
CANDIDA PARAPSILOSIS;
CANDIDA TROPICALIS;
FUNGI;
|
EID: 0035097566
PISSN: 00951137
EISSN: None
Source Type: Journal
DOI: 10.1128/JCM.39.3.949-953.2001 Document Type: Article |
Times cited : (126)
|
References (29)
|